QQQ $ 615.11 $ -4.04 (-0.65 %)
DIA $ 470.25 $ 0.57 (0.12 %)
SPY $ 672.36 $ -0.79 (-0.12 %)
TLT $ 90.13 $ 0.15 (0.17 %)
GLD $ 362.19 $ -1.27 (-0.35 %)
$ na
-- x --
-- x --
-- - --
na - na
0
na
na
na
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

MediPharm Labs (TSX:LABS) reported quarterly losses of $(0.01) per share. This is a 10 percent increase over losses of $(0.01) ...

 this-week-in-cannabis-americas-crackdown-down-on-hemp-global-reform-industry-gathering-in-chicago

Congress advances hemp THC ban as cannabis leaders prep for Benzinga's Chicago conference. Global markets shift. Here's...

Core News & Articles

MediPharm Labs (TSX:LABS) reported quarterly sales of $10.81 million which beat the analyst consensus estimate of $10.54 millio...

 cbd-pharma-co-medipharm-37-increase-in-q3-international-sales-15-yoy-revenue-growth

CBD-based pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Thursday its third qua...

 medipharm-q2-loss-narrows-adjusted-ebitda-climbs-as-gross-profit-improves-nearly-300-yoy

Cannabinoids-focused pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Wednesday f...

 executive-changes-in-cannabis-industry-you-should-know-about-new-appointments--more

Shareholders of four cannabis companies held their respective annual meetings, electing nominees as board directors.Sandy Li, w...

 cannabinoids-focused-medipharm-boasts-this-advanced-medical-cannabis-delivery-method

Cannabinoids-based pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Thursday that...

 this-cannabinoids-focused-pharma-co-sees-50-yoy-surge-in-revenue-in-2023-trims-losses

Cannabinoids-focused pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Wednesday i...

 canadian-cbd-focused-pharma-co-gets-green-light-to-produce-medical-marijuana-in-brazil

Canada's MediPharm Labs has received a GMP certification from the Brazilian governing body, ANVISA. The approval allows for...

 key-leadership-changes-in-cannabis-you-should-know-about-as-we-head-into-2024

This month, the Indigenous Cannabis Industry Association held its first Indigenous Cannabis Regulators roundtable, bringing tog...

 medipharm-labs-still-hits-c85m-despite-sequential-drop-more-on-that-in-q3-2023-financial-report

MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) reported its financial results for the three months ended September ...

 new-cannabis-products-energize-global-health--wellness-market-including-australia

In the ever-evolving world of cannabis products, innovation is the name of the game for those in search of health and wellness ...

 medipharm-settles-commercial-agreement-dispute-with-tilrays-hexo-for-9m

MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) entered into a settlement agreement on September 29, 2023 to resolve...

 new-cbd--thc-cannabis-oils-now-shipping-to-australia-from-canada

MediPharm Labs Corp.

 medipharm-delivers-cannabis-clinical-trial-material-to-us-research-partner-and-provides-update-on-fda-status

MediPharm Labs Corp. (OTCQB: MEDIF) (TSX:LABS) (FSE:MLZ) has made its first delivery to the United States, and has completed th...

 leadership-shake-ups-across-several-weed-companies-who-got-the-top-jobs

As Benzinga Cannabis Capital Conference returns to Chicago this Sept 27-28 for its 17th edition, gathering top CEOs, investors ...

 medipharm-labs-corp-q1-revenue-grows-20-yoy-achieves-first-quarter-of-positive-adjusted-ebitda

MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) announced financial results for Q1 2023, revealing EBITDA growth ove...

 medipharm-labs-begins-restructuring-following-acquisition-of-vivo-reduces-non-direct-labor-workforce-by-30

MediPharm Labs Corp. (OTCQX: MEDIF) (TSX:LABS) (FSE:MLZ) provided an update on progress made on the integration of VIVO Cannabi...

 medipharm-labs-fy22-revenue-grows-slightly-to-163m

MediPharm Labs Corp. (TSX:LABS) (OTCQX: MEDIF) (FSE:MLZ) FY 2022 revenue was CA$22.1 million ($16.3 million), an increase of 1....

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION